1	Tratamiento	tratamiento	NCMS000	C1273870#C0087111	procedimiento#r√©gimen/tratamiento	0-11	52(4)_ANS_clinical_caseMIR	SENT1	-	-
2	con	con	SPS00	C0332287	atributo	12-15	52(4)_ANS_clinical_caseMIR	SENT1	-	-
3	rifampicina	rifampicina	NCFS000	C0035608	sustancia	16-27	52(4)_ANS_clinical_caseMIR	SENT1	B-Grp_Medicamento	-
4	y	y	CC	C1706368	calificador	28-29	52(4)_ANS_clinical_caseMIR	SENT1	-	-
5	pirazinamida	pirazinamida	NC00SC0	C0034239	sustancia	30-42	52(4)_ANS_clinical_caseMIR	SENT1	B-Grp_Medicamento	-
6	durante	durante	SPS00	C1444752#C0347984	atributo	43-50	52(4)_ANS_clinical_caseMIR	SENT1	-	-
7	2	2		-	-	51-52	52(4)_ANS_clinical_caseMIR	SENT1	-	-
8	meses	mes	NCMP000	C0439231	calificador	53-58	52(4)_ANS_clinical_caseMIR	SENT1	-	-
9	.	.	Fp	-	-	58-59	52(4)_ANS_clinical_caseMIR	SENT1	-	-

